Design Therapeutics Inc (DSGN) Annual Balance Sheets

Annual · GAAP · USD millions
Access DSGN quarterly Balance Sheets →
Tracking balance sheet results across Design Therapeutics Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent16.86
Marketable Securities, Current SH202.99
Cash & Short-term Investments218.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.94
Total Current Assets223.78
Equipment/Property/Plant Net0.98
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset1.44
Total Assets226.20
Liabilities
Accounts Payable, Current AC2.31
Other Liabilities, Current10.74
Total Current Liabilities13.06
Total Long-term Debt0.00
Other liabilities, Noncurrent0.65
Operating Lease Liability Noncurrent0.65
Total Liabilities13.70
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock509.10
Retained Earnings / Accumulated Deficit-297.01
Other Equity0.40
Common Stockholder's Equity212.50
Total Stockholder's Equity212.50
Liabilities & Stockholder's Equity226.20
4 historic quarters locked

Sign in to unlock the full Design Therapeutics Inc balance sheet history.

About Design Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-098491

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License